Annual Lung SPORE Workshop (Abstract Submission)

Filter submissions
76 submissions
Created First Name Last Name Email Phone Select a Session Topic Abstract Title First Author First Name First Author Last Name Affiliation List of Additional Authors Your Abstract Submission Upload Abstract Special Characters Included? Abstract Review Status Upload Poster Poster Uploaded Operations
Tue, 02/20/2024 - 09:01 May-Lucie Meyer may-lucie.meyer@mssm.edu Session 4: Small Cell Lung Cancer, Session 6: Cancer Biology DLL3 expression in early-stage SCLC: comparative analysis of IHC and mRNA ISH May-Lucie Meyer Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA
  • First Name: Hui
    Last Name: Yu
    Affiliation: Medical Oncology, University ofColorado Anschutz Campus, Aurora, USA
  • First Name: Zoltan
    Last Name: Lohinai
    Affiliation: OKTPI-Koranyi National Institute, Budapest, Hungary
  • First Name: Grace
    Last Name: van Hyfte
    Affiliation: epartment of Population HealthScience and Policy, Icahn School of Medicine at Mount Sinai, New York, USA
  • First Name: Fred
    Last Name: Hirsch
    Affiliation: Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA
 Abstract_Submission.pdf No Approved to be a Poster Presenter DLL3 expression in SCLC Poster.jpeg
Fri, 03/08/2024 - 13:42 Shi-Yong Sun ssun@emory.edu Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Inhibition of hTERT/telomerase/telomere as an important mechanism mediating therapeutic efficacy of third generation EGFR inhibitors in EGFR mutant lung cancer Zhen Chen Emory University
  • First Name: Karin
    Last Name: Vallega
    Affiliation: Emory University
  • First Name: Dongsheng
    Last Name: Wang
    Affiliation: Emory University
  • First Name: Zhihan
    Last Name: Quan
    Affiliation: Xiangya Second Hospital
  • First Name: Songqing
    Last Name: Fan
    Affiliation: Xiangya Second Hospital
  • First Name: Qiming
    Last Name: Wang
    Affiliation: Henan Cancer Hospital
  • First Name: Ticiana
    Last Name: Leal
    Affiliation: Emory University
  • First Name: Ramalingam
    Last Name: Suresh
    Affiliation: Emory University
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 15:40 Patrick Oh patrick.oh@yale.edu Session 3: Immuno-oncology Real-World Practice Patterns of Immunotherapy, Chemotherapy, and Targeted Therapy with Radiation Therapy in Early-Stage Node-Negative Non-Small Cell Lung Cancer Patrick Oh Yale School of Medicine
  • First Name: Alexander
    Last Name: Sasse
    Affiliation: Yale School of Medicine
  • First Name: Nicholas
    Last Name: Wells
    Affiliation: Yale School of Medicine
  • First Name: So Yeon
    Last Name: Kim
    Affiliation: Yale School of Medicine
  • First Name: Sarah
    Last Name: Goldberg
    Affiliation: Yale School of Medicine
  • First Name: Henry
    Last Name: Park
    Affiliation: Yale School of Medicine
 Abstract_Submission.pdf No Approved to be a Speaker
Sun, 03/10/2024 - 20:03 Caro Kravitz caro.kravitz@yale.edu Session 6: Cancer Biology The lysine demethylase KDM2A regulates tumor cell clustering to potentiate metastasis Caro Kravitz Yale University
  • First Name: Kiran
    Last Name: Patel
    Affiliation: Yale
  • First Name: Wesley
    Last Name: Cai
    Affiliation: Yale
  • First Name: Anna
    Last Name: Arnal-Estapé
    Affiliation: Yale
  • First Name: Dejian
    Last Name: Zhao
    Affiliation: Yale
  • First Name: Emily
    Last Name: Wingrove
    Affiliation: Yale
  • First Name: Laura
    Last Name: Stevens
    Affiliation: Yale
  • First Name: Thomas
    Last Name: Westbrook
    Affiliation: Baylor
  • First Name: Qin
    Last Name: Yan
    Affiliation: Yale
  • First Name: Don
    Last Name: Nguyen
    Affiliation: Yale
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 20:25 Diane Yang dyang17@mgh.harvard.edu Session 6: Cancer Biology Profiling the protein interactome through cysteine-reactive libraries has revealed the identification of EML4ALK dimerizers Diane Yang Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Stefan
    Last Name: Harry
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Elizabeth
    Last Name: Codd
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Stefan
    Last Name: Kaluziak
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Edwin
    Last Name: Zhang
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Alexander Daniel
    Last Name: Carlin
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Zavontae
    Last Name: Oppong-Holmes
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Wendy
    Last Name: Yang
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Abigail
    Last Name: Smith
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Dawn
    Last Name: Mitchell
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Mariko
    Last Name: Hara
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Siwen
    Last Name: Zhang
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Harrison Byron
    Last Name: Chong
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Maristela
    Last Name: Onozato
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Liron
    Last Name: Bar-Peled
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: A. John
    Last Name: Iafrate
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 20:52 Matthew Wang matthew.wang.mcw69@yale.edu Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Understanding the role of alternative RNA splicing in Osimertinib resistance in lung adenocarcinoma Matthew Wang Department of Molecular Biophysics and Biochemistry, Yale University, USA
  • First Name: Robert
    Last Name: Tesng
    Affiliation: Department of Therapeutic Radiology, Yale University, USA
  • First Name: Li-Ting
    Last Name: Ku
    Affiliation: Department of Therapeutic Radiology, Yale University, USA
  • First Name: Xinning
    Last Name: Shan
    Affiliation: Department of Therapeutic Radiology, Yale University, USA
  • First Name: Joanne
    Last Name: Chen
    Affiliation: Department of Therapeutic Radiology, Yale University, USA
  • First Name: Katerina
    Last Name: Politi
    Affiliation: Department of Pathology, Yale University, USA
  • First Name: Luisa
    Last Name: Escobar-Hoyos
    Affiliation: Department of Molecular Biophysics and Biochemistry, Yale University, USA; Department of Therapeutic Radiology, Yale University, USA
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 20:59 Stefan Harry sharry@mgh.harvard.edu Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Systematic Targeting of Protein Complexes with Staples Stefan Harry Harvard University and MGH
  • First Name: Diane
    Last Name: Yang
    Affiliation: MGH
  • First Name: Liron
    Last Name: Bar-Peled
    Affiliation: MGH
  • First Name: John
    Last Name: Iafrate
    Affiliation: MGH
  • First Name: Brian
    Last Name: Liau
    Affiliation: Harvard University
 Abstract_Submission.pdf
abstract.docx13.34 KB
No Approved to be a Speaker
Mon, 03/11/2024 - 00:05 Kevin Levine klevine2@fredhutch.org Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Continued EGFR Dependency in a Patient with Lung Cancer Harboring an EGFR Kinase Domain Duplication Kevin Levine Fred Hutch Cancer Center
  • First Name: Alice
    Last Name: Berger
    Affiliation: Fred Hutch Cancer Center
  • First Name: Colin
    Last Name: Pritchard
    Affiliation: University of Washington
  • First Name: Christina
    Last Name: Baik
    Affiliation: Fred Hutch Cancer Center
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 09:03 Rebecca Starble rebecca.starble@yale.edu Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Epigenetic priming promotes acquisition of tyrosine kinase inhibitor resistance and oncogene amplification in human lung cancer Rebecca Starble Yale University
  • First Name: Eric
    Last Name: Sun
    Affiliation: Yale University
  • First Name: Rana
    Last Name: Gbyli
    Affiliation: Yale University
  • First Name: Jonathan
    Last Name: Radda
    Affiliation: Yale University
  • First Name: Jiuwei
    Last Name: Lu
    Affiliation: University of California, Riverside
  • First Name: Tyler
    Last Name: Jensen
    Affiliation: Yale University
  • First Name: Ning
    Last Name: Sun
    Affiliation: Yale University
  • First Name: Nelli
    Last Name: Khudaverdyan
    Affiliation: University of California, Riverside
  • First Name: Bomiao
    Last Name: Hu
    Affiliation: Yale University
  • First Name: Mary Ann
    Last Name: Melnick
    Affiliation: Yale University
  • First Name: Shuai
    Last Name: Zhao
    Affiliation: Duke University School of Medicine
  • First Name: Nitin
    Last Name: Roper
    Affiliation: National Cancer Institute
  • First Name: Greg
    Last Name: Wang
    Affiliation: Duke University School of Medicine
  • First Name: Jikui
    Last Name: Song
    Affiliation: University of California, Riverside
  • First Name: Katerina
    Last Name: Politi
    Affiliation: Yale University
  • First Name: Siyuan
    Last Name: Wang
    Affiliation: Yale University
  • First Name: Andrew
    Last Name: Xiao
    Affiliation: Yale University
 Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 09:40 Francisco Exposito francisco.exposito@yale.edu Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Investigating Lkb1 loss as novel synthetic vulnerability in EGFR-driven lung cancer Francisco Exposito Yale Cancer Center, New Haven; Yale School of Medicine, New Haven, USA
  • First Name: Emily
    Last Name: Shuldiner
    Affiliation: Department of Biology, Stanford University, Stanford, California 94305, USA
  • First Name: Steven
    Last Name: Lopez
    Affiliation: Department of Genetics, Stanford University, Stanford, California 94305, USA
  • First Name: Minwei
    Last Name: Wang
    Affiliation: Department of Genetics, Stanford University, Stanford, California 94305, USA
  • First Name: Mariana
    Last Name: Do Carmo
    Affiliation: Department of Pathology, Yale School of Medicine, New Haven, CT, USA
  • First Name: Laura
    Last Name: Andrejka
    Affiliation: Department of Genetics, Stanford University, Stanford, California 94305, USA
  • First Name: Giorgia
    Last Name: Foggetti
    Affiliation: Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • First Name: Christopher
    Last Name: W. Murray
    Affiliation: Department of Genetics, Stanford University, Stanford, California 94305, USA
  • First Name: Dimitri
    Last Name: Petrov
    Affiliation: Department of Biology, Stanford University, Stanford, California 94305, USA
  • First Name: Monte
    Last Name: Winslow
    Affiliation: Division of Oncology, Department of Medicine / Stanford Cancer Institute / Department of Pathology, Stanford University School of Medicine, Stanford, California
  • First Name: Katerina
    Last Name: Politi
    Affiliation: Department of Pathology, Yale School of Medicine / Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 10:46 Don Nguyen don.nguyen@yale.edu Session 1: Oncogene-driven lung cancers and resistance to targeted therapies The ATM Kinase as a Therapeutic Target in Drug Resistant NSCLC with Brain Metastasis Don Nguyen Yale School of Medicine Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 12:15 Elisabeth Martinez elisabeth.martinez@utsouthwestern.edu Session 4: Small Cell Lung Cancer Jumonji Histone Demethylases are Therapeutic Targets in Small Cell Lung Cancer Aiden Nguyen UTSW
  • First Name: Clarissa
    Last Name: Nunez
    Affiliation: UTSW
  • First Name: Tram Anh
    Last Name: Tran
    Affiliation: UTSW
  • First Name: John
    Last Name: Minna
    Affiliation: UTSW
  • First Name: Elisabeth
    Last Name: Martinez
    Affiliation: UTSW
 Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 13:09 Arnaud Augert arnaud.augert@yale.edu Session 4: Small Cell Lung Cancer The chromatin remodeling complex PBAF functions as a bona fide tumor suppressor complex in SCLC Arnaud Augert Yale University Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 12:23 Savannah Kandigian savannah.kandigian@yale.edu Session 6: Cancer Biology Molecular and histological characterization of NSCLC progression to leptomeningeal metastasis with comorbid intraparenchymal disease Savannah Kandigian Department of Pathology, Yale School of Medicine
  • First Name: Sampada
    Last Name: Chande
    Affiliation: Department of Pathology, Yale School of Medicine
  • First Name: Darin
    Last Name: Dolezal
    Affiliation: Department of Pathology, Yale School of Medicine
  • First Name: Tang
    Last Name: Tang
    Affiliation: Department of Pathology, Yale School of Medicine
  • First Name: Anna
    Last Name: Arnal-Estapé
    Affiliation: Department of Medical Oncology, Yale School of Medicine
  • First Name: Sally
    Last Name: Adua
    Affiliation: Department of Pathology, Yale School of Medicine
  • First Name: Stephanie
    Last Name: Cheok
    Affiliation: Department of Neurological Surgery, University of Southern California
  • First Name: Declan
    Last Name: McGuone
    Affiliation: Department of Pathology, Yale School of Medicine
  • First Name: Nicholas
    Last Name: Blondin
    Affiliation: Department of Neurology, Yale School of Medicine
  • First Name: Veronica
    Last Name: Chiang
    Affiliation: Department of Neurosurgery, Yale School of Medicine
  • First Name: Don
    Last Name: Nguyen
    Affiliation: Department of Pathology, Yale School of Medicine
Abstract_Submission.pdf Yes Approved to be a Poster Presenter
Mon, 03/11/2024 - 13:38 Robert Matera robert.matera@yale.edu Session 4: Small Cell Lung Cancer Longitudinal tumor microenvironment analysis in dual checkpoint inhibitor blockade using ipilimumab/nivolumab in patients with advanced stage small cell lung cancer Anne Chiang Yale University / Smilow Cancer Center
  • First Name: Robert
    Last Name: Matera
    Affiliation: Yale University / Smilow Cancer Center
  • First Name: Kerryan
    Last Name: Ashley
    Affiliation: Yale University / Smilow Cancer Center
  • First Name: Barani
    Last Name: Kumar
    Affiliation: Yale University / Smilow Cancer Center
  • First Name: Scott
    Last Name: Gettinger
    Affiliation: Yale University / Smilow Cancer Center
  • First Name: Sarah
    Last Name: Goldberg
    Affiliation: Yale University / Smilow Cancer Center
  • First Name: Roy
    Last Name: Herbst
    Affiliation: Yale University / Smilow Cancer Center
  • First Name: Frederick
    Last Name: Wilson
    Affiliation: Yale University / Smilow Cancer Center
  • First Name: Kurt
    Last Name: Schalper
    Affiliation: Yale University / Smilow Cancer Center and Yale Department of Pathology
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 13:57 Nicole Novaresi nicole.novaresi@utsw.edu Session 6: Cancer Biology Monoclonal antibodies targeting PCDH7 inhibit tumor growth and enhance response to MAPK pathway-targeted therapies in non-small cell lung cancer Nicole Novaresi Department of Molecular Biology, UTSW
  • First Name: Poorva
    Last Name: Ghosh
    Affiliation: Department of Molecular Biology, UTSW
  • First Name: Hui
    Last Name: Deng
    Affiliation: The University of Texas Health Science Center at Houston
  • First Name: Xuejun
    Last Name: Fan
    Affiliation: The University of Texas Health Science Center at Houston
  • First Name: Zhiqiang
    Last Name: Ku
    Affiliation: The University of Texas Health Science Center at Houston
  • First Name: Wei
    Last Name: Xiong
    Affiliation: The University of Texas Health Science Center at Houston
  • First Name: Xiaorong
    Last Name: Zhou
    Affiliation: Department of Molecular Biology, UTSW
  • First Name: Jingfei
    Last Name: Zhu
    Affiliation: Department of Molecular Biology, UTSW
  • First Name: Huiyu
    Last Name: Li
    Affiliation: Hamon Center for Therapeutic Oncology Research, UTSW
  • First Name: Mahesh S.
    Last Name: Padanad
    Affiliation: Department of Molecular Biology, UTSW
  • First Name: Bethany
    Last Name: Smith
    Affiliation: Department of Molecular Biology, UTSW
  • First Name: Chul
    Last Name: Ahn
    Affiliation: School of Public Health, UTSW
  • First Name: John D.
    Last Name: Minna
    Affiliation: Hamon Center for Therapeutic Oncology Research, School of Public Health, Department of Pharmacology, UTSW
  • First Name: Zhiqiang
    Last Name: An
    Affiliation: The University of Texas Health Science Center at Houston
  • First Name: Ningyan
    Last Name: Zhang
    Affiliation: The University of Texas Health Science Center at Houston
  • First Name: Kathryn A.
    Last Name: O'Donnell
    Affiliation: Department of Molecular Biology, Harold C. Simmons Comprehensive Cancer Center, Hamon Center for Regenerative Medicine, UTSW
 Abstract_Submission.pdf Yes Approved to be a Speaker
Mon, 03/11/2024 - 14:03 S. Lani Park lpark@cc.hawaii.edu Session 2: Health Disparities in Lung Cancer Racial and ethnic differences in the tumor immune microenvironment of lung adenocarcinomas Lenora Loo University of Hawaii Cancer Center
  • First Name: Alexandra
    Last Name: Binder
    Affiliation: University of Hawaii Cancer Center
  • First Name: Brenda
    Last Name: Hernandez
    Affiliation: University of Hawaii Cancer Center
  • First Name: Owen
    Last Name: Chan
    Affiliation: University of Hawaii Cancer Center
  • First Name: Lynne
    Last Name: Wilkens
    Affiliation: University of Hawaii Cancer Center
  • First Name: Kim
    Last Name: Siegmund
    Affiliation: Keck School of Medicine, University of Southern California
  • First Name: David
    Last Name: Conti
    Affiliation: Keck School of Medicine, University of Southern California
  • First Name: Loïc
    Last Name: Le Marchand
    Affiliation: University of Hawaii Cancer Center
  • First Name: S. Lani
    Last Name: Park
    Affiliation: University of Hawaii Cancer Center
 Abstract_Submission.pdf Yes Approved to be a Speaker
Mon, 03/11/2024 - 14:39 Tikvah Hayes TKHayes@mednet.ucla.edu Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Deep Mutational Scanning of EGFR Reveals Potential Domain-Specific TKI Sensitivities in Lung Cancer Tikvah Hayes UCLA Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/18/2024 - 14:34 Ken Westover kenneth.westover@utsouthwestern.edu Session 1: Oncogene-driven lung cancers and resistance to targeted therapies The On-Target MRTX1133 Resistance Mutation KRAS(R68S) Acts by Enhancing Lung Adenocarcinoma Cell Fitness Zhiwei Zhou UT Southwestern Medical Center
  • First Name: Dhiraj
    Last Name: Sinha
    Affiliation: UT Southwestern
  • First Name: Deekshi
    Last Name: Angira
    Affiliation: UT Southwestern
  • First Name: Xiaofang
    Last Name: Huo
    Affiliation: UT Southwestern
  • First Name: Michael
    Last Name: Peyton
    Affiliation: UT Southwestern
  • First Name: Kimberley
    Last Name: Avila
    Affiliation: UT Southwestern
  • First Name: John
    Last Name: Minna
    Affiliation: UT Southwestern
  • First Name: Ralf
    Last Name: Kittler
    Affiliation: UT Southwestern
  • First Name: Ken
    Last Name: Westover
    Affiliation: UT Southwestern
 Abstract_Submission.pdf No Approved to be a Speaker
Fri, 03/29/2024 - 13:18 Victoria Seewaldt victoria.seewaldt@me.com Session 2: Health Disparities in Lung Cancer The impact of diverse clinical trials personal on the diversity clinical trials participants Victoria Seewaldt City of Hope
  • First Name: Robert
    Last Name: Winn
    Affiliation: Massey Cancer Center
  • First Name: Augusto
    Last Name: Ochoa
    Affiliation: LSU Cancer center
 Abstract_Submission.pdf No Approved to be a Poster Presenter